Companies: 10,795·Total market cap: $144.5T
BiomX Inc.

BiomX Inc.

PHGEAMEXHealthcare● Active
$0.73
$-0.03(-3.96%)
Market Cap$1159001
P/E Ratio—
52W High$14.706
52W Low$0.361
SEC Filings

BiomX Inc. (PHGE) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001739174 · PHGE · AMEX · as of Jun 9, 2026

Filing snapshot

536
Total Filings
DEF 14A
Latest Form
2026-06-08
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001739174 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001213900-26-050373
Primary Document
ea0288312-10ka1_biomx.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001739174 · Accession 0001213900-26-050373

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2026-05-20
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2026-06-05Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
DEF 14AProxy Statement
DEFINITIVE PROXY STATEMENT
2026-06-08
View
8-KCurrent Report
CURRENT REPORT
2026-06-05
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-28
View
8-KCurrent Report
CURRENT REPORT
2026-05-28
View
10-QQuarterly Report
QUARTERLY REPORT
2026-05-20
View
NT 10-QNT 10-Q
NOTIFICATION OF LATE FILING
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
8-KCurrent Report
CURRENT REPORT
2026-05-05
View
10-K/AAnnual Report (Amended)
AMENDMENT NO. 1 TO FORM 10-K
2026-04-30
View
8-KCurrent Report
FORM 8-K
2026-04-16
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-15
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-14
View
8-KCurrent Report
CURRENT REPORT
2026-04-13
View
S-8Employee Stock Plan Registration
REGISTRATION STATEMENT
2026-04-10
View
8-KCurrent Report
CURRENT REPORT
2026-04-10
View
Showing 1–15 of 404 filingsForm 4 / 144 hidden· 536 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001739174  |  Exchange: AMEX · Healthcare

BiomX Inc. (AMEX: PHGE) has submitted 536 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001739174, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BiomX Inc.'s most comprehensive regulatory disclosure. The most recent BiomX Inc. 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical PHGE 10-K annual reports are available from 2018 through 2026.

Investors researching BiomX Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
EDSA SEC Filings →MPLT SEC Filings →PMN SEC Filings →ADAP SEC Filings →TRAW SEC Filings →OSRH SEC Filings →IMRN SEC Filings →BRTX SEC Filings →
→ PHGE Financials→ PHGE Earnings→ PHGE Insider Trades

Frequently Asked Questions

PHGE SEC Filings · 8 questions

BiomX Inc. (PHGE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 536 filings and access original documents at no cost. BiomX Inc.'s CIK is 0001739174.

PHGE SEC filingsBiomX Inc. SEC documentsfind PHGE 10-K